Document:

EX-10.1

 EXHIBIT 10.1 

 
  

EMPLOYMENT AGREEMENT 
  

 

 TABLE OF CONTENTS 

 

							
	 1.
	  	 DEFINED TERMS & INTERPRETATION
	  	 	1	  
			
	 2.
	  	 APPOINTMENT, POSITION AND TERM
	  	 	1	  
			
	 3.
	  	 EMPLOYEE’S DUTIES
	  	 	2	  
			
	 4.
	  	 WORKING HOURS
	  	 	3	  
			
	 5.
	  	 REMUNERATION, BENEFITS AND REVIEW
	  	 	3	  
			
	 6.
	  	 BONUS
	  	 	4	  
			
	 8.
	  	 EXPENSES
	  	 	5	  
			
	 9.
	  	 EMPLOYEE’S LEAVE AND HOLIDAYS
	  	 	5	  
			
	 10.
	  	 SICKNESS ALLOWANCE
	  	 	6	  
			
	 11.
	  	 CONFIDENTIAL INFORMATION
	  	 	6	  
			
	 12.
	  	 INTELLECTUAL PROPERTY AND MORAL RIGHTS
	  	 	7	  
			
	 13.
	  	 TERMINATION
	  	 	8	  
			
	 14.
	  	 WHAT HAPPENS AFTER TERMINATION OF EMPLOYMENT
	  	 	9	  
			
	 16.
	  	 COMPLIANCE
	  	 	10	  
			
	 17.
	  	 GENERAL
	  	 	10	  
		
	 SCHEDULE 1 - INTERPRETATION
	  	 	13	  
		
	 SCHEDULE 2 - DUTIES
	  	 	15	  
		
	 SIGNING PAGE
	  	 	17	  
		
	 ANNEXURE
	  	 	18	  

 DETAILS 
  

							
	DATE	 	January 22, 2014	 		  	
				
	PARTIES	 		 		  	
				
	Name	 	MENG Chun Cai	 	(‘Employee’)	  	
			
	Name	 	SciClone Pharmaceuticals Hong Kong Limited	  	(‘Employer’)

 AGREED TERMS 
  

	1.	DEFINED TERMS & INTERPRETATION 

 The interpretation provisions of this document
are in Schedule 1. 
  

	2.	APPOINTMENT, POSITION AND TERM 

  

	 	2.1.	Appointment and position 

 The Employer will employ the Employee in the position of
General Counsel and Vice President Compliance reporting to the President and CEO and the Audit Committee of the Board of Directors for your role as Compliance Officer. 

The Employment Agreement is contingent upon the clearance of reference and background checks satisfactory to the Company. 

 

	 	2.2.	Location 

 The Employee will be seconded to NovaMed Pharmaceuticals (Shanghai) Co., Ltd.
and will be based in 30F Shanghai Time Square, No. 93 Huai Hai Zhong Road, Shanghai 200021 China, although the Employee may be required to travel to perform the Employee’s duties and may be required to be based at a different location.

  

	 	2.3.	Commencement 

 Subject to clause 2.4 (probationary employment), the Employee’s
employment in accordance with this agreement will commence on February 8, 2014 and will continue for an indefinite period unless and until terminated in accordance with clause 13 below. 

 

	 	2.4.	Probationary employment 

 Initially, the Employee’s employment will be for a
probationary period of four (4) months unless terminated sooner: 
  

	 	2.4.1	during the first month of employment, by the Employee or Employer without notice; 

  

	 	2.4.2	after the first month of employment until the end of the probationary period, by the Employee or Employer giving one (1) week’s written notice or by paying an amount calculated in accordance with the
Employment Ordinance (Cap. 57) in lieu of notice for that period; or 

  

	 	2.4.3	by the Employer in accordance with clause 13.3 (termination without notice.) 

  
 1 

	3.	EMPLOYEE’S DUTIES 

  

	 	3.1.	Duties Employee must perform 

 The Employee must: 

 

	 	3.1.1	perform to the best of the Employee’s abilities and knowledge the duties assigned to the Employee from time to time which may include duties for the benefit of any Related Company of the Employer. The duties
initially assigned to the Employee include those listed in Schedule 2; 

  

	 	3.1.2	work such hours as are reasonably necessary to perform the Employee’s duties (overtime is not payable); 

  

	 	3.1.3	use all reasonable efforts to promote the interests of the Employer; 

  

	 	3.1.4	disclose to the Employer any facts which might involve a conflict between the Employee’s interests and the interests of the Employer; 

 

	 	3.1.5	comply with all policies of the Employer in place or as varied or replaced from time to time that are intended to apply to the Employee (although these do not form part of the Employee’s contract of employment);
and 

  

	 	3.1.6	comply with all laws and the rules and regulations of external agencies applying to the Employee’s position and the duties assigned to the Employee. 

 

	 	3.2.	What the Employee must not do 

 Without limiting the Employee’s duties, during the
Employee’s employment the Employee must not: 
  

	 	3.2.1	act in conflict with the Employer’s best interests; 

  

	 	3.2.2	on discovery, allow a conflict between the Employee’s interests and the interests of the Employer to continue; 

  

	 	3.2.3	prepare to be engaged or involved, or engage or be involved in any business or employment other than for the Employer except with the prior approval of the Employer or where the Employee holds or is interested in
investments (quoted or unquoted) representing not more than one percent (1%) of the issued investments of any class of any such company. 

  

	 	3.2.4	compete with the Employer; 

  

	 	3.2.5	in performing the Employee’s duties, accept any financial or other benefit except from the Employer; 

  

	 	3.2.6	use internet, email or voicemail at the Employer’s workplace for excessive personal use or to view or distribute offensive or illegal material; and 

 

	 	3.2.7	unlawfully discriminate or harass another person. 

  
 2 

	 	3.3.	Limits of Employee’s authority 

 The Employee must not bind the Employer in
contract, unless otherwise authorized by his supervisor. 
  

	4.	WORKING HOURS 

 The Employee’s normal working hours shall be 09:00 to
18:00 on Mondays to Fridays and such additional hours as are necessary for the proper performance of the Employee’s duties. The Employee acknowledges that the Employee shall not receive further remuneration in respect of such additional
hours. 
  

	5.	REMUNERATION, BENEFITS AND REVIEW 

  

	 	5.1.	Total Remuneration 

 During your secondment to NovaMed Pharmaceuticals (Shanghai) Co.,
Ltd., the Employer will pay the Employee RMB 1,200,000 per annum (China salary). In addition, RMB 800,000 per annum will be paid through non-taxable reimbursement subject to your submission of valid invoices from China. 

In respect of the Employee’s direct responsibilities with the Employer outside of the PRC, the Employer will pay the Employee RMB
400,000 per annum (HK salary) (or RMB 33,333 per month) payable monthly in arrears on or about the last working day of each calendar month and all days in the month are deemed to be fully paid. The Employee is responsible for
paying salaries’ tax. 
 In case of any incomplete calendar month, the salary shall be pro-rated according to the number of days, which
the Employee has actually worked during such calendar month. 
 In recognition of the benefit of the Employee’s services to the
Company, the Company will provide to the Employee with a sign-on bonus in the amount of RMB 620,000 less applicable withholdings. The sign-on bonus will be advanced to you after your first month of employment. The Employee is
responsible for paying sign-on bonus’ tax. However, in the event that the Employee voluntarily end his employment relationship prior to at least 18 months of service with the Company, the Employee promises and agrees to repay the Company the
full amount of the sign-on bonus on his resignation date. The tax amount should be able to be deducted from the Employee’s regular taxable monthly compensation for the month he voluntarily end his employment relationship. 

 

	 	5.2.	Mandatory Provident Fund Scheme 

 The Employee is entitled to participate in the
Company’s Mandatory Provident Fund (‘MPF’) Scheme in accordance with the provisions of the Mandatory Provident Fund Scheme Ordinance (Cap 485). 
  

	 	5.3.	Reimbursement 

 The non-taxable reimbursement mentioned in Section 5.1 will be paid
through reimbursement subject to the Employee providing to NovaMed Pharmaceuticals (Shanghai) Co., Ltd. with valid invoices. The reimbursement non-taxable expenses are restricted to the following items: 

 

	 	5.3.1	meal expense; 

  
 3 

	 	5.3.2	laundry expense; 

  

	 	5.3.3	housing rental expense; 

  

	 	5.3.4	two-time home trip expense of the Employee himself; 

  

	 	5.3.5	children’s school tuition; (children should be under 18 years old) 

  

	 	5.3.6	language training expense of the Employee himself; 

  

	 	5.4.	Insurance Benefits 

 During the secondment in NovaMed Pharmaceuticals (Shanghai) Co.,
Ltd., The Employer will take reasonable steps to provide for the Employee and for the Employee’s spouse and children at the Employer’s cost, medical insurance capped at RMB 12,500 per month. 

The Employer may review the remuneration and Employee’s performance not less than once each year. 

 

	6.	BONUS 

  

	 	6.1.	Bonus may be payable 

 The Employee will be eligible to participate in the
Company’s annual bonus program, under which the Employee will have an annual bonus opportunity targeted at 52.5% of the Employee then current annual base salary excluding the non-taxable reimbursement and which will be earned based on
your achievement of business objectives as established by the Chief Executive Officer in accordance with the terms of the executive bonus program. For 2014 you will be paid a fixed bonus corresponding to 100% achievement equal to RMB 770,000
(prorated for 11 months). Such bonus, if earned, shall be paid not later than the date that is two and one-half months following the close of the year in which such bonus is earned. You are responsible for paying tax on bonus payments you receive.
If there are withholding rules the company will withheld corresponding taxes. 
  

	 	6.2.	Employment until end of Bonus period 

 Despite clause 6.1 to be entitled to be paid the
Bonus, the Employee must be employed by the Employer on the date that the Bonus is paid. 
  

	 	6.3.	Bonus after first year of employment 

 Nothing in this clause is intended to restrict
the Employer’s right to determine after the end of any Bonus period whether a bonus may be payable to the Employee in a later bonus period and if so, then on what terms. 
  

	7.	OPTIONS 

  

	 	7.1.	Provision of options 

 In addition to the Total Remuneration, it will be recommended at
the first meeting of the Company’s Board of Directors following your employment start date that the company grant you an option to purchase 80,000 shares of the Company’s common stock at a price per share equal to the fair market
value per share of the Company’s common stock on the date of the first day of employment. Subject to the Employee’s continued employment, twenty-five percent 

  
 4 

 
(25%) of the option shares shall initially vest (become exercisable) on the first anniversary of your employment start date (and no shares shall vest before such date) and the remaining shares
shall vest monthly over the next thirty-six (36) months in substantially equal monthly amounts. The option shares shall be subject to the terms and conditions of the Company’s stock option plan and an appropriate form of stock option
agreement, which the Employee will be required to sign as a condition of receiving any option. Over time, additional stock option grants may be made available in the sole discretion of the Board of Directors. 

 

	 	7.2.	Conditions prior to granting of options 

 The Employee acknowledges that the Employer is
not required to offer the Employee any options in accordance with clause 7.1 until the Employee has signed this agreement. 
  

	8.	EXPENSES 

 The Employer will pay or reimburse the Employee for the Employee’s
reasonable travel and out of pocket expenses in accordance with the Employer’s expense reimbursement policy and practices. All reimbursements must be claimed promptly, but otherwise not later than the calendar month after the expense is
incurred. 
  

	9.	EMPLOYEE’S LEAVE AND HOLIDAYS 

  

	 	9.1.	Annual leave 

 Annual leave will apply as follows: 

 

	 	9.1.1	The Employer will grant the Employee annual leave of 10 Business Days in the first calendar year of employment and one additional day each year of service, with the maximum of 15 annual leave days; 

 

	 	9.1.2	for annual leave in excess of the minimum statutory requirement, the Employer may grant annual leave on a pro rata basis during the year in which it accrues or in advance; 

 

	 	9.1.3	any annual leave taken will first be applied against any statutory annual leave entitlement; 

  

	 	9.1.4	when taking annual leave, Statutory Holidays, Saturdays and Sundays will not be counted as annual leave days; 

  

	 	9.1.5	untaken annual leave in excess of the minimum statutory requirement will be forfeited, unless otherwise agreed in writing, if not taken in the year it falls due; and 

 

	 	9.1.6	subject to applicable law, on termination of the Employee’s employment other than termination in accordance with clause 13.3 (Termination without notice), the Employer will pay the Employee accrued but untaken
annual leave and pro rata annual leave calculated since the end of the last leave year at the rate the Employee would have been paid had the leave been granted. 

  

	 	9.2.	Holidays 

 The Employer will pay the Employee for Statutory Holidays although the
Employee is not required to work on these days. 
  

	 	9.3.	Rest day 

 Saturday and Sunday are rest days. 

  
 5 

	10.	SICKNESS ALLOWANCE 

 The Employee is entitled to sickness allowance in accordance with
the provisions of the Employment Ordinance (Cap. 57). 
 Application for sickness leave for more than one day must be supported by a valid
medical certificate issued by a registered medical practitioner, a Chinese medical practitioner or a registered dentist specifying the number of days for which the Employee is unfit for work and the nature of the sickness or injury on account of
which the Employee is unfit for work. Any sickness leave taken without the support of a valid medical certificate will be deemed to be unpaid or annual leave as appropriate. 

Any paid sickness leave taken by the Employee will be deducted from the sickness day credits accumulated by the Employee in accordance with
applicable law. 
  

	11.	CONFIDENTIAL INFORMATION 

  

	 	11.1.	Duty not to disclose 

 Without limiting the Employee’s duties at law, the Employee
must keep Confidential Information confidential. 
  

	 	11.2.	Exceptions to duty not to disclose 

 Notwithstanding clause 11.1, the Employee may
disclose Confidential Information: 
  

	 	11.2.1	the Employee is required to disclose in the course of the Employee’s duties with the Employer; 

  

	 	11.2.2	that was public knowledge when this agreement was signed or became so at a later date (other than as a result of a breach of confidentiality by the Employee); or 

 

	 	11.2.3	that the Employee is required by a court, tribunal or law to disclose (in which event, the Employee must inform the Employer prior to disclosure). 

 

	 	11.3.	Disclosure in the course of the Employee’s duties 

 The Employee may only disclose
Confidential Information under clause 11.2.1 if: 
  

	 	11.3.1	the disclosure is solely for the purpose of performing the Employee’s duties with the Employer; and 

  

	 	11.3.2	the disclosure is to persons who: 

  

	 	11.3.2.1	are aware and agree that the Confidential Information must be kept confidential; or 

  

	 	11.3.2.2	have signed any confidentiality obligation required by the Employer from time to time; 

  

	 	11.3.2.3	have a need to know (and only to the extent that each has a need to know); or 

  

	 	11.3.2.4	have been approved by the person or persons nominated by the Employer from time to time. 

  
 6 

	 	11.4.	Preservation of Confidential Information 

 The Employee must take whatever measures are
reasonably necessary to preserve the Confidential Information, including: 
  

	 	11.4.1	complying with all security measures established to safeguard Confidential Information from access or unauthorised use; 

  

	 	11.4.2	keeping Confidential Information under the Employee’s control; and 

  

	 	11.4.3	not removing Confidential Information from, or accessing Confidential Information from outside, the Employer’s premises without the prior approval of the Employer. 

 

	 	11.5.	Notification of breach 

 The Employee must immediately notify the Employer of any
suspected or actual unauthorised use, copying or disclosure of Confidential Information. 
  

	 	11.6.	Indemnification 

 The Employee hereby undertakes to indemnify and keep indemnified the
Employer against any loss or damage suffered by the Employer arising from the breach of the Employee’s obligations under this clause 11. Notwithstanding the aforesaid and without prejudice to any other rights or remedies that the Employer may
have, the Employee acknowledges and agrees that damages alone would not be an adequate remedy for any breach by the Employee of this clause 11, and accordingly the Employer shall be entitled, without proof of special damages, to the remedies of
injunction, specific performance or other equitable relief for any threatened or actual breach of this clause 11. 
  

	12.	INTELLECTUAL PROPERTY AND MORAL RIGHTS 

  

	 	12.1.	Assignment by Employee 

 The Employee: 

 

	 	12.1.1	presently assigns to the Employer all existing and future Intellectual Property Rights in all inventions, models, designs, drawings, plans, software, reports, proposals and other materials created or generated by the
Employee (whether alone or with the Employer, its other employees, agents or contractors) for use by the Employer (or a Related Company of the Employer); and 

  

	 	12.1.2	acknowledges that by virtue of this clause, all such existing rights are vested in the Employer and, on their creation, all such future rights will vest in the Employer. 

 

	 	12.2.	Employee’s assistance 

 The Employee must do all things reasonably requested by the
Employer to enable the Employer to assure further the rights assigned under clause 12.1. 

  
 7 

	 	12.3.	Moral Rights 

 The Employee: 

 

	 	12.3.1	voluntarily and unconditionally consents to all or any acts or omissions by the Employer, or persons authorised by the Employer, in relation to any and all works made or to be made by the Employee (whether before or
after this consent is given) in the course of the employment (‘Works’) which would otherwise infringe the Employee’s Moral Rights; 

  

	 	12.3.2	waives any and all existing and future Moral Rights in the Works; and 

  

	 	12.3.3	acknowledges that the Employee has given this consent 

  

	 	12.3.3.1	voluntarily; and 

  

	 	12.3.3.2	without reliance on any statement or representation made by the Employer, a Related Company of the Employer or anyone acting on their behalf. 

 

	13.	TERMINATION 

  

	 	13.1.	Termination with notice or payment in lieu 

 After the probationary period ends, either
the Employer or the Employee may at any time terminate the Employee’s employment. Employee shall give to the Employer notice of 30 days in writing of the Employee’s intention to do so. Even though the Employee’s position, title or
report may change during the employment, unless otherwise agreed the period of notice of termination will not change. 
  

	 	13.2.	Employment during notice period 

 Following the provision of notice to terminate the
Employee’s employment by either party or, if the Employer is undertaking an investigation at any time during the employment, the Employer may by written notice require the Employee not to perform any services (or to perform only specified
services) for the Employer or any Related Company of the Employer until the termination of the employment or a specified date. 
 During any
period of Garden Leave, the Employer shall be under no obligation to provide any work to, or vest any powers in the Employee, who shall have no right to perform any services for the Employer or any Related Company of the Employer. 

During any period of Garden Leave the Employee shall: 
  

	 	13.2.1	continue to receive salary and all contractual benefits in the usual way and subject to the terms of any benefit arrangement; 

  

	 	13.2.2	remain an employee of the Employer and bound by the terms of this agreement; 

  

	 	13.2.3	not, without the prior written consent of the Employer, attend the Employee’s place of work or any other premises of the Employer; 

 

	 	13.2.4	not, without the prior written consent of the Employer, contact or deal with (or attempt to contact or deal with) any officer, employee, consultant, client, customer, supplier, agent, distributor, shareholder, advisor
or other business contact of the Employer or any Related Company of the Employer; and 

  

	 	13.2.5	(except during any periods taken as holiday in the usual way) ensure that the Employer knows where the Employee will be and how the Employee can be contacted during each working day and shall comply with any written
requests to contact a specified employee of the Employer at specified intervals. 

  
 8 

	 	13.3.	Termination without notice 

 The Employee’s employment maybe terminated by the
Employer at any time without notice if the Employee: 
  

	 	13.3.1	disobeys proper legal reason a lawful direction of the Employer; 

  

	 	13.3.2	is guilty of serious misconduct; 

  

	 	13.3.3	breaches clause 11 (Confidential Information); 

  

	 	13.3.4	materially fails to perform the Employee’s duties; 

  

	 	13.3.5	unlawfully discriminates or harasses any other person; 

  

	 	13.3.6	breaches any material provision of this agreement; 

  

	 	13.3.7	is found guilty by a court of a serious criminal offence; 

  

	 	13.3.8	has accepted employment with the Employer in breach of clause 16.1 (Warranties); 

  

	 	13.3.9	becomes a bankrupt; or 

  

	 	13.3.10	is guilty of a serious breach of any rules issued by the Employer from time to time. 

 If the
Employee’s employment is terminated without notice, then the Employer will pay the Employee’s Total Remuneration, Benefits and MPF up to the date of termination. 
  

	14.	WHAT HAPPENS AFTER TERMINATION OF EMPLOYMENT 

  

	 	14.1.	Requirements following termination 

 If the Employee’s employment is terminated for
any reason, then: 
  

	 	14.1.1	the Employee must resign from the Employer and any Related Company of the Employer without claim for compensation for loss of office, and the Employee authorises the Company Secretary of the Employer to do all things
necessary to give effect to such resignations on the Employee’s behalf; 

  

	 	14.1.2	the Employee must return all the Employer’s property (including property leased by the Employer) to the Employer on termination including all written or machine readable material, Confidential Information,
software, computers, credit cards, keys and vehicles; 

  

	 	14.1.3	the Employee’s obligations under clause 11 (Confidential Information) continue after termination; and 

  

	 	14.1.4	the Employee must not record any Confidential Information in any form after termination. 

  
 9 

	 	14.2.	Employee’s assistance with legal proceedings 

 After the Employee’s employment
ends, the Employer may require the Employee to assist in any threatened or actual legal or other proceedings in which the Employer or a Related Company of the Employer is involved, for which the Employee will be reimbursed all reasonable costs. 

 

	15.	COMPLIANCE 

 The exercise of or compliance with any discretion, right or obligation under
this agreement is subject to: 
  

	 	15.1.	compliance with all applicable laws; 

  

	 	15.2.	compliance with the Memorandum and Articles of the Employer; and 

  

	 	15.3.	the approval of the shareholders of the Employer where such approval is required. 

If the approval of the shareholders of the Employer is required before a payment may be made to the Employee, then the board of directors of
the Employer must ensure that the approval of the members is sought. 
  

	16.	GENERAL 

  

	 	16.1.	Warranties by Employee 

 The Employee warrants: 

 

	 	16.1.1	other than what the Employee has disclosed to the Employer in writing, the Employee is not involved and has not been involved in any litigation with any previous employer; 

 

	 	16.1.2	that the Employee has disclosed to the Employer information about any possible restrictions on the Employee from performing the Employee’s duties set out in this agreement; 

 

	 	16.1.3	other than what the Employee has disclosed to the Employer, that the Employee is not restricted from performing the Employee’s duties for the Employer arising from a restrictive covenant or other non-competition
obligation owed to anyone, or a restriction imposed on the Employee concerning the use of any information or the intellectual property rights of anyone; 

  

	 	16.1.4	that the credentials and information provided by the Employee to the Employer (or to the Employer’s agent) touching upon the Employee’s qualifications and ability to perform the duties under this agreement are
true and correct; 

  

	 	16.1.5	other than what the Employee has disclosed to the Employer, that prior to accepting employment, the Employee has not suffered from an occupational disease in any trade, industry or process; 

 

	 	16.1.6	that the Employee has all the necessary licences, permissions, consents, approvals, qualifications and memberships required of the Employee to perform the duties under this agreement and that the Employee has never been
suspended, censured or otherwise subjected to any disciplinary action or other proceeding, litigation or investigation by any state or governmental body or agency or any regulatory authority or self-regulatory organisation; 

  
 10 

	 	16.1.7	that the Employee is not a person subject to any statutory disqualification under the Companies Ordinance (Cap.32) and that the Employee has not been the cause of any other person or entity becoming subject to any
statutory disqualification; and 

  

	 	16.1.8	that the Employee shall comply with all applicable law and regulation including, without limitation, the applicable codes and guidelines issued by the Hong Kong Securities and Futures Commission from time to time.

  

	 	16.2.	Notification of restrictions 

 The Employee agrees that in the event of receiving from
any person, company, business entity or other organisation an offer of employment or for services (whether oral or in writing) either during the continuance of this agreement or during the continuance in force of any of the restrictions set out in
clause 11, the Employee will forthwith provide to such offeror a full and accurate copy of these clauses 11 and notify the Employer of such offer. The Employee further agrees that if the Employee accepts any such offer, the Employee will forthwith
(i) notify the Employer of the identity of the offeror, (ii) provide the Employer with a description of the principal duties of the position accepted; and (iii) confirm to the Employer in writing that the Employee has provided a copy
of these clauses to the offeror. 
  

	 	16.3.	Right to vary 

 The Employer reserves the right to vary any of the terms and conditions
of this agreement at any time in its reasonable discretion. 
  

	 	16.4.	Severability 

 Part or all of any clause of this agreement that is illegal or
unenforceable will be severed from this agreement and the remaining provisions continue in force. 
  

	 	16.5.	Waiver 

 The failure of either party at any time to insist on performance of any
provision of this agreement is not a waiver of their right at any later time to insist on performance of that or any other provision of this agreement. 
  

	 	16.6.	Governing Law 

 This agreement is governed by the law applicable in Hong Kong SAR and
the parties irrevocably and unconditionally submit to the exclusive jurisdiction of the court of Hong Kong SAR. 
  

	 	16.7.	Agreement is confidential 

 This agreement including any amendments is confidential and
may not be disclosed by the Employee to any other person, other than for the purpose of obtaining professional legal or accounting advice, without the prior approval of the Employer. 

  
 11 

	 	16.8.	Entire agreement 

 This agreement (including its Schedules): 

 

	 	16.8.1	constitutes the entire agreement between the Employer and Employee as to its subject matter; and 

  

	 	16.8.2	as to its subject matter, supersedes and cancels any contract, deed, arrangement, related condition, collateral arrangement, condition, warranty, indemnity or representation imposed, given or made by the Employer or
Employee (or an agent of either of them) prior to entering into this agreement. 

  

	 	16.9.	Release from prior arrangements 

 The Employee releases the Employer from all claims and
demands touching upon any contract, deed, arrangement, related condition, collateral arrangement, condition, warranty, indemnity or representation imposed, given or made by one of them (or an agent of one of them) prior to entering into this
agreement. 
  

	 	16.10.	Data privacy 

 The Employee must sign the Employee Collection Statement annexed to this
agreement. 
  

	 	16.11.	Deduction of sums owed 

 To the extent permitted by law, at any time during the
Employee’s employment, or upon its termination (howsoever arising), the Employer shall be entitled to deduct from the Employee’s remuneration (or from any other payments due to the Employee in respect of the employment or its termination)
any monies due from the Employee to the Employer including, without limitation, any outstanding loans, advances, overpayment of wages, the cost of repairing any damage or loss to the Employer’s property caused by him (and of recovering the
same), excess annual leave pay and any other monies owed by him to the Employer. 
  

	 	16.12.	Counterparts 

 This agreement may be executed in counterparts. 

 

	 	16.13.	Force Majeure 

 This agreement shall be terminated with immediate effect and neither
part y shall be liable for a breach of this agreement nor liable for any failure in performance of any obligations under this agreement (save and except the Employee’s post-termination duties set out in clause 11 (Confidentiality) and 15
(Restraint on an Employee’s conduct) which shall survive the termination of this agreement) arising from or attributable to acts, events, omissions or accidents beyond its reasonable control (Force Majeure Event). 

A Force Majeure Event shall include, but is not limited to, any act of God, war, fire, flood, drought, tempest, epidemic or pandemic,
terrorist attack and collapse of building structure. 

  
 12 

 SCHEDULE 1 - INTERPRETATION 

 

	1.	DEFINITIONS 

 In this document, unless the context otherwise requires, the following
words have these meanings. 
 Business Day means any day in Hong Kong SAR other than Saturdays, Sundays and a general holiday as
defined in the General Holidays Ordinance Cap. 149. 
 Confidential Information means all confidential information of the Employer or
a Related Company of the Employer including but not limited to the terms of this agreement (and any amendments or variations thereof), trade secrets, confidential know-how, client lists, supplier lists, price lists, information about tenders and
proposals to prospective clients, prospective client lists, information about products and services in development, business plans, marketing plans and computer software owned or used by the Employer or a Related Company of the Employer of which the
Employee becomes aware or generates (both before and after the day this agreement is signed) touching upon the Employee’s employment with the Employer. 

Garden Leave means any period during which the Employer has exercised its rights under clause 13.2. 

Intellectual Property Rights means all intellectual property rights including without limitation: 

 

	 	(a)	patents, copyrights, rights in circuit layouts, registered designs, trademarks and the right to have Confidential Information kept confidential; and 

 

	 	(b)	any application or right to apply for registration of the rights in (a). 

 Moral Rights
means any and all rights conferred by Division IV Part II of the Copyright Ordinance Cap. 528. 
 MPF means a mandatory provident fund
as defined in the Mandatory Provident Fund Schemes Ordinance Cap. 485. 
 Related Company has the meaning as that term is defined in
section 49BA(9) of the Companies Ordinance Cap. 32. 
 Statutory Holidays mean the statutory holidays as defined in the Employment
Ordinance (Cap. 57). 
  

	2.	INTERPRETATION 

 In this document, unless the contrary intention appears: 

 

	 	(a)	(singular/plural) words denoting the singular include the plural and vice versa; 

  

	 	(b)	(reference to any instrument) a reference to any instrument (such as a deed, agreement or document) is to that instrument (or, if required by the context, to a part of it) as amended, novated, substituted or
supplemented at any time and from time to time; 

  

	 	(c)	(headings) headings are for ease of reference only and do not affect the meaning of this document. 

  
 13 

	3.	SCHEDULE AND ANNEXURE 

 The Schedules and annexure form part of this document. 

  
 14 

 SCHEDULE 2 - DUTIES (CLAUSE 3.1.1) 

The duties initially assigned include: 
 This position will have
primary responsibility for SciClone’s company-wide compliance programs, legal affairs and global legal strategies. This position plans and directs programs, policies, and practices to ensure that all business units’ activities are in
compliance with regulatory requirements. This position tracks laws and regulations in China, the USA, as well as in other countries relevant for the business of the Company that might affect the organizations policies and implements necessary
changes. 
 The General Counsel position will have responsibility for all legal matters in the USA, China as well as the Cayman companies including SciClone
and all its subsidiaries. It coordinates with the Chief Financial Officer, of SciClone work regarding corporate legal matters. 
 The following will be the
key priorities and requirements of the position: 
 Legal Affairs 

Responsible for overseeing all legal matters pertaining to the organization, including patent, copyright, intellectual property and employment law matters and
the coordination of any legal matters handled by outside counsel. Develops functional plans for managing legal matters, including activities to be performed in-house or through third-party relationships to best manage SciClone’s legal
activities and minimize risk for the business. Oversee the retention and management of outside counsel. 
 Provide advice and counsel on a day-to-day basis
with respect to all laws, rules and regulations governing the commercial sale of pharmaceuticals, in China, Hong Kong and other countries where SciClone Pharmaceuticals International Ltd is doing business. 

Prepare and review commercial agreements, including clinical trial, marketing, distribution, and other commercial agreements to ensure agreements reflect
SciClone’s business objectives and to ensure compliance with all applicable laws, rules and regulations. Coordinate the contract review, approval and record keeping processes with business development and U.S. and China finance. 

Advise on other legal matters relevant for the business including employment, real estate or other matters in China 

In addition to the above responsibilities, we would anticipate that you would over time take increasing responsibility for the following areas: 

In conjunction with our outside counsel and our Finance and Accounting team, participate in the preparation of filings with the Securities and Exchange
Commission. 
 In conjunction with outside legal counsel, advise the Board of Directors on legal matters. 

Compliance 
 Lead the development, implementation
and/or review of SciClone’s compliance policies and procedures to ensure continued compliance and identify potential areas of risk with US and China laws, unethical or improper conduct. 

Respond to alleged violations of rules, regulations, policies, procedures, and the Code of Conduct by evaluating or recommending the initiation of
investigative procedures. 

  
 15 

 Act as an independent review and evaluation body to ensure that compliance issues and concerns with the
organization are being appropriately evaluated, investigated, and resolved. 
 Monitor and coordinate compliance activities of other departments to remain
abreast of the status of all compliance activities. 
 Provide reports on a regular basis and, as directed or requested, keep the Audit Committee of the
Board of Directors of SciClone and President and CEO of SciClone informed of the operation and progress of compliance efforts. 

  
 16 

 SIGNING PAGE 

IN WITNESS whereof this agreement has been executed and delivered as a Deed on the day and year first before written. 

 

					
	Executed as a deed by or on behalf of SciClone Pharmaceuticals Hong Kong Limited acting by	 		  	
			
	Friedhelm Blobel, Ph.D., Director	 		  	
			
		 		  	 /s/ Friedhelm Blobel

			
		 		  	Signature of Friedhelm Blobel, Ph.D.
			
	SIGNED SEALED AND DELIVERED BY	 		  	[Name, address [and occupation] of witness]
			
	MENG Chun Cai:	 		  	
			
		 		  	In the presence of:
			
	 /s/ Chun Cai Meng
	 		  	  

			
	Signature of Chun Cai Meng	 		  	[Signature of witness]

  
 17 

 ANNEXURE 

ANNEXURE TO EMPLOYMENT 
 AGREEMENT EMPLOYEE COLLECTION

 STATEMENT 
 Your privacy is important to SciClone
Pharmaceuticals Hong Kong Limited (‘Company’). 
 Throughout the course of your employment with the Company, the Company needs to collect personal
data from you and about you. The type of information that may be collected includes (but is not limited to): 
  

	 	•	 	Recruitment, engagement or training records; 

  

	 	•	 	Information about your medical condition; 

  

	 	•	 	Information regarding termination of employment; 

  

	 	•	 	Terms and conditions of employment; 

  

	 	•	 	Personal and emergency contact details; 

  

	 	•	 	Performance, conduct and disciplinary records; 

  

	 	•	 	Remuneration details, bonus and share plan information; 

  

	 	•	 	Membership of professional associations or trade unions; 

  

	 	•	 	Leave records (including annual leave, sick leave and maternity leave); 

  

	 	•	 	Taxation, banking and mandatory provident fund details; 

  

	 	•	 	Health and safety information; 

  

	 	•	 	Any other information that you provide to the Company. 

 The purposes for which the Company collects this data
is for use concerning your employment or working relationship with the Company and for various human resources, management and reporting purposes. 
 The
Company from time to time transfers your personal data to the following classes of persons: 
  

	 	•	 	a Related Company (as defined in section 49BA(9) of the Companies Ordinance Cap.32); 

  

	 	•	 	the Company’s insurers and banks; 

  

	 	•	 	medical practitioners appointed by the Company; 

  

	 	•	 	administrator of the Company’s mandatory provident fund scheme; 

  

	 	•	 	outside parties involved in a merger, acquisition or due diligence exercise; 

  

	 	•	 	companies the Company engages to perform the functions listed above on the Company’s behalf; and 

  

	 	•	 	anyone you authorise. 

 If you do not provide complete and accurate personal data to the Company as and when it
is required, there may be potentially serious consequences for you and, depending on the circumstances, your future employment relationship with the Company. 

It is the Company’s policy to retain certain personal data of employees when they cease to be employed. This data may be required for any residual
employment-related activities, including for example, provision of references, processing of applications for re-employment, matters relating to retirement benefits and allowing the Company to fulfil any of the Company’s contractual or
statutory obligations. 
 To the extent applicable law allows, you may request access to, and correction of, your personal data in relation to your
employment. For any further information, please contact Friedhelm Blobel. 

  
 18 

 Please indicate your understanding and acceptance of the above by signing and returning the acknowledgement form
below to Friedhelm Blobel. 
  
  

Acknowledgment 
 I have read and fully understand the above
contents and acknowledge that I accept these terms voluntarily and freely. 
  

					
	 Chun Cai Meng
	 		 	 /s/ Chun Cai Meng

	Name of employee	 		 	Signature of employee
			
	  
	 		 	
	Date	 		 	

  
 19EX-10.2

 EXHIBIT 10.2 

SCICLONE PHARMACEUTICALS, INC. 

CHANGE IN CONTROL AGREEMENT 
 This
Change in Control Agreement (the “Agreement”) is effective as of February 9, 2014 by and between MENG Chun Cai (the “Employee”) and SciClone Pharmaceuticals, Inc., a Delaware corporation (the
“Company”). 
 RECITALS 

A. The Employee presently serves as Vice President, Compliance and Legal Affairs of the Company and performs significant strategic and
management responsibilities necessary to the continued conduct of the Company’s business and operations. 
 B. The Board of Directors
of the Company (the “Board”) has determined that it is in the best interests of the Company and its stockholders to assure that the Company will have the continued dedication and objectivity of the Employee, notwithstanding the
possibility or occurrence of a Change in Control (as defined below) of the Company. 
 C. The Board believes that it is imperative to
provide the Employee with certain severance benefits upon the Employee’s termination of employment following a Change in Control that will provide the Employee with enhanced financial security and provide sufficient incentive and encouragement
to the Employee to remain with the Company following a Change in Control. 
 AGREEMENT 

The Employee and the Company agree as set forth below: 

1. Terms of Employment. The Company and the Employee agree that the Employee’s employment is based on the original offer letter
and labor contract terms and that their employment relationship may be terminated by either party at any time, with or without Cause, and, if applicable, in accordance with Section 2 below. If the Employee’s employment with the Company
terminates for any reason following a Change in Control, but on or before the first anniversary of the Change in Control, the Employee shall not be entitled to any payments, benefits, damages, awards or compensation other than as provided by this
Agreement. During his employment with the Company, the Employee agrees to devote his full business time, energy and skill to his duties with the Company. These duties shall include, but not be limited to, any duties consistent with the
Employee’s position that may be assigned to the Employee from time to time by the Company or the Board. 

  
 1 

 2. Severance Benefits Upon Termination following a Change in Control. Subject to the
limitations set forth in Sections 3 and 4 below, if the Employee’s employment with the Company terminates following a Change in Control but on or before the first anniversary of such Change in Control, then the Employee shall be entitled
to receive, in addition to the compensation and benefits earned by the Employee through the date of his termination, severance benefits as follows: 

(a) Involuntary Termination. If the Employee’s employment with the Company is terminated as a result of Involuntary Termination,
then the Employee shall be entitled to receive the following severance benefits: 
 (i) The Employee shall be entitled to receive severance
pay in an amount equal to one hundred percent (100%) of his annual base salary and allowances as in effect at the time of such termination (at the time of entering into this agreement an amount of RMB 2,300,000). Any severance to which the
Employee is entitled pursuant to this section shall be paid in a lump sum, less applicable withholding, within thirty (30) days following the Employee’s termination. 

(ii) The Executive shall be entitled to receive a separation bonus equal to the gross amount of fifty percent (50%) of the average
annual performance bonus paid to the Executive for the two (2) most recent fiscal years for which bonuses have been paid prior to the termination date. 

(iii) With respect to any unvested options to purchase shares of the stock of the Company held by the Employee; Section 12.1 (b) of
the 2005 Equity Incentive Plan, as amended (the “Plan”), notwithstanding, if a Change in Control occurs and the “Acquiror”, as defined in the Plan, does not assume the “Awards”, as defined in the Plan, held by Employee,
then all such Awards held by Employee shall become fully vested and exercisable as of a date ten (10) business days prior to the occurrence of the closing of the transaction resulting in the Change in Control, with any acceleration and exercise
subject to, and conditional upon, the actual closing of such transaction.” 
 (iv) The Employee shall be entitled to exercise all
vested options to purchase shares of the stock of the Company held be the Employee (including any options to purchase shares that become vested for a period of twelve (12) months after the date of such termination (notwithstanding anything to
the contrary otherwise provided under the terms and conditions of such options). 
 (v) The Company shall, if permitted under the
Company’s existing health insurance plans, continue the Executive’s existing group health insurance coverage. If not so permitted, the Company shall reimburse the Executive for any health insurance premiums paid by the Executive for
continued group health insurance coverage. Such health insurance coverage or reimbursement of premiums shall continue until the earlier of (i) twelve (12) months after the date of the Executive’s Involuntary Termination or
(ii) the date on which the Executive commences New Employment. 
 (b) Voluntary Resignation; Termination For Cause. If the
Employee’s employment terminates by reason of the Employee’s voluntary resignation (but not as a result of an Involuntary Termination) or as a result of the Employee’s termination for Cause, then the Employee shall not be entitled to
receive any severance pay or benefits under this Agreement. 
 (c) Disability; Death. If the Company terminates the Employee’s
employment as a result of the Employee’s Disability, or death, then the Employee shall not be entitled to receive any severance pay or benefits under this Agreement. 

  
 2 

 3. Release of Claims; Resignation. The Employee’s entitlement to any severance pay or
benefits under Section 2(a) is conditioned upon the Employee’s execution and delivery to the Company of (a) a general release of known and unknown claims in the form attached hereto as Exhibit A and (b) a resignation from all of
the Employee’s positions with the Company, including from the Board of Directors and any committees thereof on which the Employee serves, in a form satisfactory to the Company. 

4. Parachute Payments. In the event that any payment or benefit received or to be received by the Employee pursuant to this Agreement
or otherwise (collectively, the “Payments”) would result in a “parachute payment” as described in section 280G of the Internal Revenue Code of 1986, as amended, notwithstanding the other provisions of this Agreement,
the amount of such Payments will not exceed the amount which produces the greatest after-tax benefit to the Employee. For purposes of the foregoing, the greatest after-tax benefit will be determined within thirty (30) days of the occurrence of
such payment to the Employee, in the Employee’s sole and absolute discretion. If no such determination is made by the Employee within thirty (30) days of the occurrence of such payment, the Company will promptly make such determination in
a fair and equitable manner. 
 5. Consulting Services. During the six (6) months following any Involuntary Termination for
which the Employee receives the severance pay and benefits described in Section 2(a), the Employee shall be retained by the Company as an independent contractor to provide consulting services to the Company at its request for up to eight
(8) hours per week. These services shall include any reasonable requests for information or assistance by the Company, including, but not limited to, the transition of the Employee’s duties. Such services shall be provided at mutually
convenient times. For the actual provision of such services, the Company shall pay to the Employee a consulting fee of $1,000 per eight hour day, plus reasonable out-of-pocket expenses (for example, travel and lodging). 

6. Company’s Successors. Any successor to the Company or to all or substantially all of the Company’s business and/or assets
will be bound by this Agreement in the same manner and to the same extent as the Company. For all purposes under this Agreement, the term “Company” will include any successor to the Company’s business and/or assets. 

7. Employee’s Successors. All rights of Employee hereunder will inure to the benefit of, and be enforceable by, Employee’s
personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. The Employee will have no right to assign any of his obligations or duties under this Agreement to any other person or entity. 

8. Definition of Terms. The following terms referred to in this Agreement shall have the following meanings: 

(a) “Cause” shall mean any of the following: 

(i) the Employee’s theft, dishonesty, misconduct or falsification of any records of the Company, its successor, or any subsidiary of the
Company or its successor (collectively, the “Company Group”); 

  
 3 

 (ii) the Employee’s misappropriation or improper disclosure of confidential or proprietary
information of the Company Group; 
 (iii) any intentional action by the Employee which has a material detrimental effect on the reputation
or business of the Company Group; 
 (iv) the Employee’s failure or inability to perform any reasonable assigned duties after written
notice from the Company Group of, and a reasonable opportunity to cure, such failure or inability; 
 (v) any material breach by the
Employee of any employment agreement between the Employee and the Company Group, which breach is not cured pursuant to the terms of such agreement; or 

(vi) the Employee’s conviction of any criminal act which impairs the Employee’s ability to perform his duties for the Company
Group. 
 (b) “Change in Control” shall mean: (i) a merger or other transaction in which the Company or
substantially all of its assets is sold or merged and as a result of such transaction, the holders of the Company’s common stock prior to such transaction do not own or control a majority of the outstanding shares of the successor corporation,
(ii) the election of nominees constituting a majority of the Board which nominees were not approved by a majority of the Board prior to such election, or (iii) the acquisition by a third party of twenty percent (20%) or more of the
Company’s outstanding shares which acquisition was without the approval of a majority of the Board in office prior to such acquisition. 

(c) “Constructive Termination” shall mean any one or more of the following: 

(i) without the Employee’s express written consent, the assignment to the Employee, following the Change in Control, of any title or
duties, or any limitation of the Employee’s responsibilities, that are substantially inconsistent with the Employee’s title(s), duties, or responsibilities with the Company Group immediately prior to the date of the Change in Control; 

(ii) without the Employee’s express written consent, the relocation of the principal place of the Employee’s employment, following
the Change in Control, to a location that is more than fifty (50) miles from the Employee’s principal place of employment immediately prior to the date of the Change in Control, or the imposition of travel requirements substantially more
demanding of the Employee than such travel requirements existing immediately prior to the date of the Change in Control; 
 (iii) any
failure by the Company Group, following the Change in Control, to pay, or any material reduction by the Company Group of, (1) the Employee’s base salary in effect immediately prior to the date of the Change in Control, or (2) the
Employee’s bonus compensation, if any, in effect immediately prior to the date of the Change in Control (subject to applicable performance requirements with respect to the actual amount of bonus compensation earned by the Employee), unless base
salary and/or bonus reductions comparable in amount and duration are concurrently made for a majority of the other employees of the Company Group who have substantially similar titles and responsibilities as the Employee; and 

  
 4 

 (iv) any failure by the Company Group, following the Change in Control, to (1) continue to
provide the Employee with the opportunity to participate, on terms no less favorable than those in effect for the benefit of any employee group which customarily includes a person holding the employment position or a comparable position with the
Company Group then held by the Employee, in any benefit or compensation plans and programs, including, but not limited to, the Company Group’s life, disability, health, dental, medical, savings, profit sharing, stock purchase and retirement
plans, if any, in which the Employee was participating immediately prior to the date of the Change in Control, or in substantially similar plans or programs, or (2) provide the Employee with all other fringe benefits (or substantially similar
benefits), including, but not limited to, relocation benefits, provided to any employee group which customarily includes a person holding the employment position or a comparable position with the Company Group then held by the Employee, which the
Employee was receiving immediately prior to the date of the Change in Control. 
 However, the foregoing conditions shall not constitute a Constructive
Termination unless the Employee has given written notice of any such condition(s) to the Chairman of the Board and allowed the Company Group at least twenty (20) days thereafter to correct such condition(s). If such condition(s) are not
corrected within that twenty (20) day period, the Employee may give written notice of his Constructive Termination to the Board, which shall be an Involuntary Termination. 

(d) “Disability” means the inability of the Employee, in the opinion of a qualified physician, to perform the
essential functions of the Employee’s position with the Company Group, with reasonable accommodation, because of the sickness or injury of the Employee. 

(e) “Involuntary Termination” shall mean the occurrence of either of the following events after a Change in Control,
but on or before the first anniversary of such Change in Control: 
 (i) termination by Company Group of the Employee’s employment
without Cause; or 
 (ii) the Employee’s Constructive Termination. 

“Involuntary Termination” shall not include any termination of the Employee’s employment that is (1) for Cause, (2) a result of the
Employee’s death or Disability, or (3) a result of the Employee’s voluntary resignation. 
 (f) “New
Employment” shall mean any employment obtained by the Employee after the termination of the Employee’s employment with the Company. 

9. Nonsolicitation. During his employment with the Company, and for a period of one (1) year following the termination of his
employment for any reason, the Employee shall not directly or indirectly recruit, solicit, or induce any person who on the date hereof is, or who subsequently becomes, an employee, sales representative or consultant of the Company, to terminate his
relationship with the Company. 

  
 5 

 10. Successors. 

(a) Company’s Successors. Any successor to the Company or to all or substantially all of the Company’s business and/or assets
shall be bound by this Agreement in the same manner and to the same extent as the Company. For all purposes under this Agreement, the term “Company” shall include any successor to the Company’s business and/or assets. 

(b) Employee’s Successors. All rights of the Employee hereunder shall inure to the benefit of, and be enforceable by, the
Employee’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. The Employee shall have no right to assign any of his obligations or duties under this Agreement to any other
person or entity. 
 11. Notice. 

(a) General. Notices and all other communications contemplated by this Agreement shall be in writing and shall be deemed to have been
duly given when personally delivered or when mailed by U.S. registered or certified mail, return receipt requested and postage prepaid. In the case of the Employee, mailed notices shall be addressed to the Employee at the home address which he most
recently communicated to the Company in writing. In the case of the Company, mailed notices shall be addressed to its corporate headquarters, and all notices shall be directed to the attention of its Secretary. 

(b) Notice of Termination. Any termination by the Company Group or the Employee of their employment relationship shall be communicated
by a written notice of termination to the other party. 
 12. Miscellaneous Provisions. 

(a) No Duty to Mitigate. The Employee shall not be required to mitigate the amount of any payment contemplated by this Agreement
(whether by seeking New Employment or in any other manner), nor shall any such payment be reduced by any earnings that the Employee may receive from any other source. 

(b) Waiver. No provision of this Agreement shall be modified, waived or discharged unless the modification, waiver or discharge is
agreed to in writing and signed by the Employee and by an authorized officer of the Company (other than the Employee). No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party
shall be considered a waiver of any other condition or provision or of the same condition or provision at another time. 
 (c) Choice of
Law. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of California. 

  
 6 

 (d) Severability. The invalidity or unenforceability of any provision or provisions of
this Agreement shall not affect the validity or enforceability of any other provision hereof, which shall remain in full force and effect. 

(e) Arbitration. Any dispute, controversy or claim arising out of or relating to this contract, including the validity, invalidity,
breach or termination thereof, shall be settled by arbitration in Hong Kong under the Hong Kong International Arbitration Centre Administered Arbitration Rules in force with the Notice of Arbitration is submitted in accordance with these rules.
Judgment upon any decision or award rendered by the arbitrator may be entered in any court having jurisdiction over the matter. The Employee and the Company knowingly and willingly waive their respective rights to have any such disputes or claims
tried to a judge or jury. 
 (f) Prior Agreements. This Agreement supersedes all prior understandings and agreements, whether written
or oral, regarding the subject matter of this Agreement. 
 IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case
of the Company by its duly authorized officer, as of the day and year first above written. 
  

			
	SCICLONE PHARMACEUTICALS, INC.
		
	By:	 	 /s/ Friedhelm Blobel

  

	
	EMPLOYEE
	
	 /s/ Chun Cai Meng

	MENG Chun Cai

  
 7 

 Exhibit A 

RELEASE 
 In exchange for
the severance pay and benefits described in the Executive Severance Agreement between SciClone Pharmaceuticals, Inc. (the “Company”) and me of February 9, 2014, I hereby release the Company, its parents and subsidiaries,
and their officers, directors, employees, attorneys, stockholders, successors, assigns and affiliates, of and from any and all claims, liabilities, and causes of action of every kind and nature, whether known or unknown, based upon or arising out of
any agreements, events, acts, omissions or conduct at any time prior to and including the execution date of this Release, including, but not limited to: all claims concerning my employment with the Company or the termination of that employment; all
claims pursuant to any PRC Labor Contract Law and the regulations promulgated by the local government having jurisdiction over the employment. 

I am knowingly, willingly and voluntarily releasing any claims I may have under relevant local laws. I acknowledge that the consideration
given for the release in the preceding paragraph hereof is in addition to anything of value to which I was already entitled. 
 I hereby
waive and relinquish all rights and benefits under that section and any law of any jurisdiction of similar effect with respect to my release of any unknown claims I may have, and I affirm that it is my intention to release all known and unknown
claims that I have or may have against the parties released above. 

 This Release contains the entire agreement between the Company and me regarding the subjects
above, and it cannot be modified except by a document signed by me and an authorized representative of the Company. 
  

									
		 		 		 	EMPLOYEE
				
	Date:	 	  
	 		 	  

		 		 		 	MENG Chun Cai
				
		 		 		 	SCICLONE PHARMACEUTICALS, INC.
					
	Date:	 	  
	 		 	By:	 	  

					
		 		 		 	Its:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00231-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00231-of-00352.parquet"}]]